Usefulness of high-sensitivity C-Reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction☆
Section snippets
Study objectives and hypotheses
Our objectives were to test (1) whether CRP is equally predictive of long-term clinical outcomes (death [D] or AMI) in patients with angiographically similar CAD presenting with AMI as in those presenting with stable angina pectoris (SAP) or unstable angina pectoris (UAP), and (2) whether the predictive value of CRP overall and in the specific diagnostic subgroups is altered by adjustment for multiple standard risk factors. We postulated that CRP values would be higher after AMI than after SAP
All patients
Baseline demographics of the 1,360 patients with CAD overall and by diagnostic subgroup are summarized in Table 1. Patients averaged 65 years of age (range 33 to 95), and 77% were men. After AMI, ejection fraction, blood pressure, and lipid levels were lower and CRP higher; however, there were no significant differences among groups in the number of severely stenotic coronary vessels and in D/AMI events.
For the overall cohort, CRP was a highly significant univariable and multivariable
Study perspective
In our large CAD cohort with up to 5 years follow-up, we found that CRP was strongly predictive of long-term outcome in patients with SAP and UAP, but not after recent AMI despite higher levels (2.5 vs 1.3 mg/dl). Because the 3 CAD subgroups had comparable angiographic CAD and therapy, we interpret this failure in the AMI group as reflecting a distortion in chronic levels caused by the acute phase reaction associated with myocardial injury. In non-AMI patients, the adjusted relative hazard of
References (25)
- et al.
C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction
Am J Cardiol
(1999) - et al.
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe Coronary artery disease
J Am Coll Card
(2000) - et al.
Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase
Am J Cardiol
(1997) - et al.
Comparson of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris
Am J Cardiol
(1998) - et al.
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromesa TIMI 11A substudy. Thromolysis in Myocardial Infarction
J Am Coll Cardiol
(1998) - et al.
Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris
Am J Cardiol
(1998) - et al.
Predictive value of C-reactive protein and troponin T in patients with unstable anginaa comparative analysis. CAPTURE investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina Refractory to standard treatment trial
J Am Coll Cardiol
(2000) - et al.
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
N Engl J Med
(1997) - et al.
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
N Engl J Med
(2000) - et al.
Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
Lancet
(1997)
Serum C-reactive protein kinetics after acute myocardial infarction
J Clin Invest
Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment
Eur Heart J
Cited by (184)
Targeted imaging: the key for direct visualization of myocardial inflammation in patients?
2023, Journal of Nuclear CardiologyHigh-Sensitivity C-Reactive Protein
2023, Clinical Lipidology: A Companion to Braunwald's Heart DiseaseAcute Myocardial Infarction Biosensor: A Review From Bottom Up
2021, Current Problems in CardiologyCitation Excerpt :CRP monitoring is the best way to prevent future clinical events due to coronary factors like myocardial infarction.5,179 According to studies reported in literature, levels of this protein increase during the first 8-12 hours since the appearance of symptoms for AMI (normal level in healthy person: less than 1 mg/dl) and return to baseline 3-4 weeks later.159,250 In this case, marker levels are related to infarct size and are reduced by acute reperfusion.250
Meta-analysis of C-Reactive Protein and Risk of Angina Pectoris
2020, American Journal of CardiologyInflammation during acute coronary syndromes — Risk of cardiovascular events and bleeding
2019, International Journal of Cardiology
- ☆
This study was supported in part by the Deseret Foundation, Intermountain Health Care, Salt Lake City, Utah; and by Grant 5T32HL07576 from the National Heart, Lung, and Blood Institutes, National Institutes of Health, Bethesda, Maryland.